Michal leads cross-border mergers and acquisitions, advising tech and life sciences companies in game-changing M&A, including deSPACs, reverse mergers, negotiated and unsolicited transactions, and joint ventures. Her clients include strategic and private equity buyers and sellers in public and private transactions. She is dual qualified in New York and England and Wales.

Download full bio 


  • Redx Pharma to Merge With Jounce Therapeutics 

  • Bavarian Nordic Acquires Emergent BioSolutions’ Travel Vaccines Portfolio 

  • Biote Agrees to Combine With SPAC Haymaker Acquisition Corp. III 

  • Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II 

  • Baylis Medical Agrees to Sell to Boston Scientific for $1.75 Billion 

  • View all

Outstanding. Smart, can-do and entrepreneurial attitude. Always available, very commercial, and a pleasure to work with. – Legal 500, Corporate & Commercial M&A, 2023

  • University of Pennsylvania Law School
    JD, 1997

  • Johns Hopkins University
    BA, 1994

Admissions & Credentials

England & Wales

New York

Rankings & Accolades

    The Legal 500 UK: M&A  (2022)
    Chambers & Partners (UK): Leading Individual - Corporate/ M&A (2022)